We expanded the scope of our business beyond assessing drugs and medical devices to responding to a range of COVID-19–related questions.

This entry was posted on Wednesday, July 14th, 2021 at 8:33 pm and is filed under . You can follow any responses to this entry through the RSS 2.0 feed. Both comments and pings are currently closed.

Comments are closed.